Cargando…
Rapid SARS-CoV-2 Seroprevalence Survey in Central and Western Divisions of Fiji, 2021
During November–December 2021, we performed a SARS-CoV-2 seroprevalence survey in Central and Western Divisions of Fiji. A total of 539 participants 8–70 years of age were 95.5% (95% CI 93.4%–97.1%) seropositive, indicating high community levels of immunity. Seroprevalence studies can inform public...
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Centers for Disease Control and Prevention
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796197/ https://www.ncbi.nlm.nih.gov/pubmed/36573643 http://dx.doi.org/10.3201/eid2901.221514 |
| _version_ | 1784860428123242496 |
|---|---|
| author | Curtis, Stephanie J. Shah, Abdul W. Ratu, Ana Wilson, Donald J. Hill, Philip C. Hulcome, Phil Gaylard, Cathy Faktaufon, Daniel Cabemaiwai, Talica Rabukawaqa, Isireli Qoriniasi, Tevita Narayan, Akesh Nakalevu, Susana Romakin, Pablo Tudravu, Jemesa Fong, James Walsh, Nick |
| author_facet | Curtis, Stephanie J. Shah, Abdul W. Ratu, Ana Wilson, Donald J. Hill, Philip C. Hulcome, Phil Gaylard, Cathy Faktaufon, Daniel Cabemaiwai, Talica Rabukawaqa, Isireli Qoriniasi, Tevita Narayan, Akesh Nakalevu, Susana Romakin, Pablo Tudravu, Jemesa Fong, James Walsh, Nick |
| author_sort | Curtis, Stephanie J. |
| collection | PubMed |
| description | During November–December 2021, we performed a SARS-CoV-2 seroprevalence survey in Central and Western Divisions of Fiji. A total of 539 participants 8–70 years of age were 95.5% (95% CI 93.4%–97.1%) seropositive, indicating high community levels of immunity. Seroprevalence studies can inform public health responses to emerging SARS-CoV-2 variants. |
| format | Online Article Text |
| id | pubmed-9796197 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Centers for Disease Control and Prevention |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97961972023-01-09 Rapid SARS-CoV-2 Seroprevalence Survey in Central and Western Divisions of Fiji, 2021 Curtis, Stephanie J. Shah, Abdul W. Ratu, Ana Wilson, Donald J. Hill, Philip C. Hulcome, Phil Gaylard, Cathy Faktaufon, Daniel Cabemaiwai, Talica Rabukawaqa, Isireli Qoriniasi, Tevita Narayan, Akesh Nakalevu, Susana Romakin, Pablo Tudravu, Jemesa Fong, James Walsh, Nick Emerg Infect Dis Research Letter During November–December 2021, we performed a SARS-CoV-2 seroprevalence survey in Central and Western Divisions of Fiji. A total of 539 participants 8–70 years of age were 95.5% (95% CI 93.4%–97.1%) seropositive, indicating high community levels of immunity. Seroprevalence studies can inform public health responses to emerging SARS-CoV-2 variants. Centers for Disease Control and Prevention 2023-01 /pmc/articles/PMC9796197/ /pubmed/36573643 http://dx.doi.org/10.3201/eid2901.221514 Text en https://creativecommons.org/licenses/by/4.0/Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
| spellingShingle | Research Letter Curtis, Stephanie J. Shah, Abdul W. Ratu, Ana Wilson, Donald J. Hill, Philip C. Hulcome, Phil Gaylard, Cathy Faktaufon, Daniel Cabemaiwai, Talica Rabukawaqa, Isireli Qoriniasi, Tevita Narayan, Akesh Nakalevu, Susana Romakin, Pablo Tudravu, Jemesa Fong, James Walsh, Nick Rapid SARS-CoV-2 Seroprevalence Survey in Central and Western Divisions of Fiji, 2021 |
| title | Rapid SARS-CoV-2 Seroprevalence Survey in Central and Western Divisions of Fiji, 2021 |
| title_full | Rapid SARS-CoV-2 Seroprevalence Survey in Central and Western Divisions of Fiji, 2021 |
| title_fullStr | Rapid SARS-CoV-2 Seroprevalence Survey in Central and Western Divisions of Fiji, 2021 |
| title_full_unstemmed | Rapid SARS-CoV-2 Seroprevalence Survey in Central and Western Divisions of Fiji, 2021 |
| title_short | Rapid SARS-CoV-2 Seroprevalence Survey in Central and Western Divisions of Fiji, 2021 |
| title_sort | rapid sars-cov-2 seroprevalence survey in central and western divisions of fiji, 2021 |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796197/ https://www.ncbi.nlm.nih.gov/pubmed/36573643 http://dx.doi.org/10.3201/eid2901.221514 |
| work_keys_str_mv | AT curtisstephaniej rapidsarscov2seroprevalencesurveyincentralandwesterndivisionsoffiji2021 AT shahabdulw rapidsarscov2seroprevalencesurveyincentralandwesterndivisionsoffiji2021 AT ratuana rapidsarscov2seroprevalencesurveyincentralandwesterndivisionsoffiji2021 AT wilsondonaldj rapidsarscov2seroprevalencesurveyincentralandwesterndivisionsoffiji2021 AT hillphilipc rapidsarscov2seroprevalencesurveyincentralandwesterndivisionsoffiji2021 AT hulcomephil rapidsarscov2seroprevalencesurveyincentralandwesterndivisionsoffiji2021 AT gaylardcathy rapidsarscov2seroprevalencesurveyincentralandwesterndivisionsoffiji2021 AT faktaufondaniel rapidsarscov2seroprevalencesurveyincentralandwesterndivisionsoffiji2021 AT cabemaiwaitalica rapidsarscov2seroprevalencesurveyincentralandwesterndivisionsoffiji2021 AT rabukawaqaisireli rapidsarscov2seroprevalencesurveyincentralandwesterndivisionsoffiji2021 AT qoriniasitevita rapidsarscov2seroprevalencesurveyincentralandwesterndivisionsoffiji2021 AT narayanakesh rapidsarscov2seroprevalencesurveyincentralandwesterndivisionsoffiji2021 AT nakalevususana rapidsarscov2seroprevalencesurveyincentralandwesterndivisionsoffiji2021 AT romakinpablo rapidsarscov2seroprevalencesurveyincentralandwesterndivisionsoffiji2021 AT tudravujemesa rapidsarscov2seroprevalencesurveyincentralandwesterndivisionsoffiji2021 AT fongjames rapidsarscov2seroprevalencesurveyincentralandwesterndivisionsoffiji2021 AT walshnick rapidsarscov2seroprevalencesurveyincentralandwesterndivisionsoffiji2021 |